Celularity Inc (CELU)

Nov 20, 2024

Celularity Partners with Genting to Build $7.2B Market-Targeting Stem Cell Facility in Bali | CELU Stock News - StockTitan

Nov 20, 2024

Nov 18, 2024

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - The Manila Times

Nov 18, 2024

Nov 18, 2024

Celularity Resolves Nasdaq Compliance Issue, Maintains Listing After Filing Reports | CELU Stock News - StockTitan

Nov 18, 2024

Nov 17, 2024

Celularity Inc. (NASDAQ:CELU) Sees Large Increase in Short Interest - MarketBeat

Nov 17, 2024

Nov 11, 2024

After-Market Momentum: Celularity (CELU) Shares Climb On Increased Guidance - Stocks Telegraph

Nov 11, 2024

Nov 09, 2024

Celularity sets annual meeting date, stockholder proposal deadline By Investing.com - Investing.com Canada

Nov 09, 2024

Nov 08, 2024

Celularity sets annual meeting date, stockholder proposal deadline - Investing.com India

Nov 08, 2024

Nov 07, 2024

Celularity Inc. (CELU) Quarterly 10-Q Report - Quartzy

Nov 07, 2024

Nov 07, 2024

Celularity Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Nov 07, 2024

Nov 07, 2024

U.S. Stock market: Celularity(+52.68%), Applovin(+45.14%), FARO Technologies(+33.01%) and others were among the top gainers during mid day trading - Business Upturn

Nov 07, 2024

Nov 07, 2024

Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million - The Manila Times

Nov 07, 2024

Nov 07, 2024

Celularity Raises 2024 Sales Forecast to $60M After Record-Breaking October Revenue | CELU Stock News - StockTitan

Nov 07, 2024

Oct 31, 2024

CELU stock touches 52-week low at $1.55 amid market fluctuations - Investing.com India

Oct 31, 2024

Oct 30, 2024

CELU stock touches 52-week low at $1.55 amid market fluctuations By Investing.com - Investing.com South Africa

Oct 30, 2024

Oct 26, 2024

Celularity reports over $24 million in biomaterial revenue By Investing.com - Investing.com Australia

Oct 26, 2024

Oct 26, 2024

Celularity Inc. Announces Anticipated Revenues for Second and Third Quarters - Defense World

Oct 26, 2024

Oct 25, 2024

Celularity reports over $24 million in biomaterial revenue - Investing.com India

Oct 25, 2024

Oct 25, 2024

Celularity Receives Nasdaq Delisting Notice Over Filing Delay - Marketscreener.com

Oct 25, 2024

Oct 23, 2024

Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel - The Manila Times

Oct 23, 2024

Oct 23, 2024

Celularity reports progress on Nasdaq compliance and product sales - Investing.com

Oct 23, 2024

Oct 22, 2024

Celularity reports progress on Nasdaq compliance and product sales By Investing.com - Investing.com Australia

Oct 22, 2024

Oct 22, 2024

Celularity Provides Corporate Update - citybiz

Oct 22, 2024

Oct 22, 2024

CELUWCelularity Inc. Warrant Latest Stock News & Market Updates - StockTitan

Oct 22, 2024

Oct 22, 2024

Celularity to submit 510(k) notification for Tendon Wrap in early 2025 - TipRanks

Oct 22, 2024

Oct 21, 2024

Celularity faces Nasdaq delisting over reporting delays - Investing.com

Oct 21, 2024

Oct 21, 2024

Celularity faces Nasdaq delisting over reporting delays By Investing.com - Investing.com UK

Oct 21, 2024

Oct 18, 2024

Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal - ForexTV.com

Oct 18, 2024

Oct 17, 2024

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc. - The Manila Times

Oct 17, 2024

Oct 16, 2024

Celularity expands biomaterials range with Rebound acquisition - Investing.com India

Oct 16, 2024

Oct 16, 2024

Celularity Inc SEC 10-Q Report - TradingView

Oct 16, 2024

Oct 08, 2024

Stem Cell Umbilical Cord Blood Market Report 2024, with Profiles of Cryo-Cell, Cordlife, ViaCord, CryoHoldco, LifeCell, StemCyte, Celularity Cryo-Save and Vita 34 - Yahoo Finance

Oct 08, 2024

Oct 03, 2024

Celularity (NASDAQ:CELU) Stock Price Down 8.8%Should You Sell? - MarketBeat

Oct 03, 2024

Sep 19, 2024

Amniotic Membrane Market to Grow by USD 2.7 Billion (2024-2028) with AI Impact Boosting Trends in Ophthalmic Surgery UseTechnavio Report - The Malaysian Reserve

Sep 19, 2024

Sep 18, 2024

BTIG maintains Buy rating on Cullinan Oncology stock - Investing.com

Sep 18, 2024

Sep 18, 2024

Cullinan Oncology maintains Buy rating from H.C. Wainwright with steady price target - Investing.com India

Sep 18, 2024

Sep 18, 2024

Trend Tracker for (CLS) - Stock Traders Daily

Sep 18, 2024

Sep 18, 2024

Cullinan Therapeutics (NASDAQ:CGEM) Earns Outperform Rating from Wedbush - MarketBeat

Sep 18, 2024

Sep 18, 2024

Caesars Entertainment Inc (CZR) stock: A year of ups and downs - US Post News

Sep 18, 2024

Sep 18, 2024

In the Green: Cerus Corp. (CERS) Closes at 1.97, Up/Down -4.37 from Previous Day - The Dwinnex

Sep 18, 2024

Sep 18, 2024

Creo Medical to get £25m boost from majority sale of its European business - Business Live

Sep 18, 2024

Sep 18, 2024

Medical device company to sell stake of subsidiary to Chinese manufacturerequity value of €72m - Insider Media

Sep 18, 2024

Sep 18, 2024

Objective long/short (CGEM) Report - Stock Traders Daily

Sep 18, 2024

Sep 18, 2024

CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA - Yahoo Finance

Sep 18, 2024

Sep 18, 2024

Cullinan Therapeutics Inc (CGEM)’s stock price in review: A technical analysis - US Post News

Sep 18, 2024

Sep 18, 2024

(CELC) Technical Pivots with Risk Controls - Stock Traders Daily

Sep 18, 2024

Sep 18, 2024

Creo Medical Partners with Micro-Tech for Strategic Growth - TipRanks

Sep 18, 2024

Sep 18, 2024

E Fund Management Co. Ltd. Purchases New Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) - MarketBeat

Sep 18, 2024

Sep 18, 2024

State of New Jersey Common Pension Fund D Has $3.31 Million Stock Holdings in Caesars Entertainment, Inc. (NASDAQ:CZR) - Defense World

Sep 18, 2024

Sep 18, 2024

Cellectis (NASDAQ:CLLS) Coverage Initiated at StockNews.com - MarketBeat

Sep 18, 2024

Sep 18, 2024

Cullinan Therapeutics commences Phase 1 trial for lupus treatment By Investing.com - Investing.com Canada

Sep 18, 2024